Essex, United Kingdom

Matthew Keith Fordham

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Keith Fordham. Retrieved from https://idiyas.com/inventor/matthew-keith-fordham-128qxq1w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthew Keith Fordham and an Oral Drug Delivery Device.

Introduction

Matthew Keith Fordham is an inventor associated with Essex, Great Britain, and Eli Lilly and Company. His patent work includes a device designed to deliver medication directly through the gastrointestinal tract. The available information identifies 1 patent associated with him.

Latest Patents

Fordham’s listed patent is titled “Oral Drug Delivery Device with Expanding Arms.” The device is taken orally and activates inside the gastrointestinal tract. Its resilient arms expand to engage the tract walls, while a driver moves a plunger that pushes medication through channels in the arms and into the surrounding tissue. After a period of time, at least part of the device dissolves, allowing it to pass through the gastrointestinal tract.

Career Highlights

The described invention focuses on a specialized approach to oral drug delivery. By combining expandable arms, a plunger, and a dissolvable device structure, it is designed to deliver medication at a targeted location within the gastrointestinal tract. Fordham is associated with Eli Lilly and Company.

Collaborations

The provided information names Maria Fernandez-Martos Balson and Jack Alexander Hornsby as Fordham’s coworkers. Their specific roles in developing or patenting the device are not stated.

Conclusion

Matthew Keith Fordham’s listed patent describes an oral drug delivery device that expands within the gastrointestinal tract to deliver medication and later partially dissolves.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…